About Child Health Institute
The Child Health Institute of New Jersey is a comprehensive biomedical research center dedicated to improving child health through the study of mechanisms underlying children's diseases. The groundbreaking research of the Institute's scientists is integrated with the clinical approaches of pediatric physicians to understand the causes, and improve the therapy and prevention of childhood illness.
The Institute is the cornerstone of the children's academic health campus in New Brunswick and collaborates in its research initiatives with Rutgers Robert Wood Johnson Medical School's Department of Pediatrics and Pediatric Clinical Research Center, The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital, and PSE&G Children's Specialized Hospital. Together, they form a unique partnership of world-class institutions representing an exciting opportunity for the translation of research findings into improved pediatric care.
There are four major areas of research at Child Health Institute:
Inflammatory, immune and infectious diseases of childhood: Researchers are collaborating with pediatricians at the medical school to investigate autoimmune disorders, asthma and type 1 diabetes. The team is working to establish two multidisciplinary centers: the Center for Asthma Research and the Center for Type 1 Diabetes. Institute investigators also collaborate with pediatric rheumatologists investigating diseases such as pediatric lupus and juvenile idiopathic arthritis.
Neurodevelopment and autism: The Institute has recruited outstanding scientists who work with colleagues across Robert Wood Johnson Medical School and Rutgers, as well as with clinicians at PSE&G Children’s Specialized Hospital, to study the causes and treatments of autism and other neurodevelopmental disorders. The high rates of autism in New Jersey lend urgency to this research.
Pediatric cancers and stem cells: Institute investigators are working with scientists at Rutgers Cancer Institute of New Jersey to understand how pediatric cancers, including leukemia, arise from mutated tissue stem cells. They are also studying how adult stem cells may be used as novel therapies in regenerative and reparative medicine.
Childhood obesity and metabolism: In collaboration with pediatricians and scientists at the Rutgers Robert Wood Johnson Medical School and across Rutgers, Institute investigators are studying the neurological, genetic, environmental, and inflammatory causes of obesity and its consequences for the long term.
CHI Welcomes New Board Members
Canaan E. Himmelbaum, Esq.
Canaan Himmelbaum currently serves as the Vice President of Business Development for Advanced Discovery. In this role, Mr. Himmelbaum oversees Business Development and Consulting for a global eDiscovery Corporation. Mr. Himmelbaum also leverages his years of experience working in-house as Litigation and eDiscovery Counsel at Glanbia, PLC where he worked on large scale eDiscovery litigation and M&A matters. He advises and consults with Clients that are part of Advanced Discovery’s Healthcare, Food/Beverage, Oil/Gas/Energy and Antitrust Groups. He consults on planning and budgeting, internal investigations and information governance.
Additionally, Mr. Himmelbaum has a long history of philanthropic fundraising and is a staunch advocate for children’s health. Mr. Himmelbaum is active with the Hudson Shea Foundation, which raises awareness and funds to help the continued research surrounding pre-term labor and stillbirths. Having suffered the loss of a child (Stella Faith) to pre-term labor, Mr. Himmelbaum and the Hudson Shea Foundation host monthly bereavement groups for Father’s who have suffered the loss of a child. This is Mr. Himmelbaum’s motivation to continue his support for medical research.
Charles E. Denardo
Charles Denardo is the President of Lease Line, Inc. He is a senior business executive with a bottom-up history compiling forty years of professional experience cultivating positive sales, marketing and partnership strategies in the highly competitive truck leasing industry. His education and business understanding began as a mechanic and truck driver, fueling his desire to develop a dynamic and customer focused family business. During his tenure as President, Lease Line has continued to grow and prosper, even as increased competition and a volatile business climate have made things extremely challenging.
Mr. Denardo is also active in the municipal government of Millstone Township where he serves on the Open Space and Farmland Preservation Council. Mr. Denardo has a long standing commitment to bettering the lives of children in New Jersey and beyond and is excited to contribute his experience and expertise to the growth of CHINJ.
Donation Establishes New Child Health Research Fund
The Child Health Institute of New Jersey received a $100,000 donation from the Hudson Shea Foundation to create the Hudson Shea and Stella Faith Research Fund in pregnancy loss and prematurity. The funds will be awarded yearly to support the research of an outstanding Rutgers investigator whose work strives to understand the fundamental causes of preterm birth and associated life-threatening neonatal disorders, with the hope of finding preventive measures or a cure. The mission of the Hudson Shea Foundation is to raise awareness and medical funding for perinatal and infant death. The foundation also provides platforms for grief counseling services and perinatal bereavement groups. The Hudson Shea Foundation honors and remembers all lost babies at its annual Angel Walk, being held on Saturday, September 17, 2016, at 10 a.m. at Van Saun County Park in Paramus.
Visit the Hudson Shea Foundation or its Facebook page to learn more or register for the Angel Walk.
New Members to its Board of Directors:
Canaan E. Himmelbaum, Esq.
Vice President, Business Development
Charles E. Denardo
Lease Line, Inc.
CHI SCIENCE SEMINARS 2016-2017
Download the schedule here:
CHI SCIENCE SEMINAR SCHED 2016-2017